CHEMICAL and STRUCTURAL APPROACHES to RATIONAL DRUG DESIGN
2020
Chemical Approaches to Rational Drug Design Design, Synthesis and Antitumor Activity of an Inhibitor of Ribonucleotide Reductase, J.R. McCarthy and P.S. Sunkara. The Development of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitors, A. Stern. The Development of Potent Angiotensin II Receptor Antagonists Using a Novel Peptide Pharmacophore Model, R.M. Keenan, J. Weinstock, J.C. Hempel, J.M. Samanen, D.T. Hill, N. Aiyar, E.H. Ohlstein, and R.M. Edwards. Endothelin Structure and Development of Receptor Antagonists, A.M. Doherty. Molecular Targeting Chemistry in Rational Drug Design, A. Fritzberg, L. Gustavson, M. Hylarides, and J. Reno. Structural Approaches to Rational Drug Design The Role of X-Ray Crystallography in Structure-Based Rational Drug Design, A. McPherson. Biocomputational Approaches to Protein-Based Drug Design, K. Prammer, M. Weiner, and T. Kieber-Emmons. Architecture and Design of Zinc Protein-Ligand Complexes, D.W. Christianson and A.M. Khoury Christianson. Design of Immunomodulatory Peptides Based on Active Site Structures, A.B. Mukherjee and L. Miele. Index.